Privileged access is hard to govern in clinical environments because operational urgency, third-party support, and device administration often create pressure for standing access. Once access is used across multiple teams or systems, accountability becomes blurred. Healthcare programmes need shorter access duration, clearer approval paths, and separate review evidence for elevated access.
Why Privileged Access Becomes Hard to Govern in Clinical Settings
Clinical environments compress decision time, expand the number of systems that need elevated access, and make access paths harder to separate from normal care delivery. That combination pushes teams toward standing privilege, shared break-glass accounts, and broad vendor support access, even when policy says otherwise. Guidance from the NIST Cybersecurity Framework 2.0 and the Ultimate Guide to NHIs both point to the same reality: governance fails when access is not tied to clear ownership, lifecycle controls, and review evidence. NHI Mgmt Group reports that only 20% of organisations have formal offboarding and revocation processes for API keys, which is a strong indicator of how often elevated access outlives the task it was meant to support. In practice, many security teams discover privilege sprawl only after a support incident, audit finding, or device outage has already created operational pressure to keep it.
What Good Governance Looks Like in Practice
Effective clinical governance starts by treating elevated access as temporary and attributable, not as a blanket entitlement. For human users, that means just-in-time approval, short session windows, and separate evidence for each elevated action. For non-human identities, that means workload-scoped credentials, strong ownership, and rotation or revocation at task completion. The OWASP Non-Human Identity Top 10 is useful here because it frames the problem as lifecycle and secret exposure, not just access requests. The Lifecycle Processes for Managing NHIs section highlights why issuance, use, rotation, and offboarding must be evidenced separately.
- Separate emergency access from routine administrative access, with distinct approvals and logs.
- Use just-in-time elevation for device admins, analysts, and support staff rather than standing privilege.
- Assign each privileged account or secret to one owner and one purpose, then review both regularly.
- Prefer short-lived tokens over long-lived credentials, especially for third-party or vendor access.
- Record who approved access, why it was granted, when it expires, and what was done during the session.
For clinical devices, the hardest part is usually not the policy itself but proving that the same access path is not being reused across wards, vendors, and after-hours support. These controls tend to break down when shared accounts, unmanaged device consoles, and urgent remote support all converge in one workflow because attribution and revocation become too slow to keep pace.
Where the Standard Model Breaks Down and What to Watch
Tighter privileged access controls often increase coordination overhead, so organisations have to balance speed of care against the cost of stronger evidence and tighter expiry windows. That tradeoff is real in radiology, biomedical engineering, and outsourced device maintenance, where a delayed login can delay treatment. Current guidance suggests treating these cases as exceptions with explicit expiry, but there is no universal standard for every clinical workflow yet. The Regulatory and Audit Perspectives note that auditors care less about the label on the access and more about whether revocation, review, and accountability can be demonstrated. The Top 10 NHI Issues resource is also relevant because many “privileged access” failures in healthcare are actually secrets governance failures.
Edge cases include vendor-maintained imaging platforms, shared biomedical consoles, and emergency break-glass workflows. In those environments, the practical goal is not perfect denial of access but rapid containment: isolate the privilege, shorten the lifetime, and capture evidence that can be reviewed later. The most common failure mode is allowing emergency access to become routine access because no one owns the cleanup after the incident ends.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 and OWASP Non-Human Identity Top 10 address the attack and risk surface, while NIST CSF 2.0 and NIST AI RMF set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | PR.AC-4 | Privileged access governance depends on managing and reviewing elevated access rights. |
| OWASP Non-Human Identity Top 10 | NHI-03 | Clinical privilege often relies on secrets that must be rotated and revoked reliably. |
| OWASP Non-Human Identity Top 10 | NHI-06 | Shared and overexposed identities are a common cause of blurred accountability in hospitals. |
| NIST AI RMF | Clinical privilege decisions need governance, accountability, and risk-based oversight. |
Eliminate shared privileged accounts where possible and assign accountable ownership for each identity.
Related resources from NHI Mgmt Group
- Who is accountable when privileged access controls fail in cloud environments?
- How should security teams govern non-human identities that have persistent access?
- How should security teams govern non-human identities in cloud environments?
- How should security teams govern API keys used for generative AI access?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on June 23, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
